Wealthspring Capital’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Wealthspring Capital’s Portfolio LVACU Stock Details LVACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-42,000	Closed	-$422K	–	517
2022 Q3	$422K	Hold	42,000	–	–	0.08%	335
2022 Q2	$420K	Sell	42,000 -5,000	-11%	-$50.3K	0.08%	348
2022 Q1	$473K	Sell	47,000 -5,000	-10%	-$50.6K	0.09%	304
2021 Q4	$523K	Buy	+52,000	New	+$526K	0.11%	256

Other funds holding LVACU

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wealthspring Capital's LVACU Position: Q4 2022 in Review

Wealthspring Capital sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q4 2022, closing a stake of 42,000 shares — an estimated $422K sold.

Wealthspring Capital first reported a position in LVACU in Q4 2021 and held it in 4 quarters. The position peaked at $523K in Q4 2021. 6 funds tracked by Wall St. Rank hold LVACU as of Q4 2022.

Wealthspring Capital reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
Wealthspring Capital sold 42,000 LAVA Medtech Acquisition Corp. Unit shares in Q4 2022, an estimated $422K.
Wealthspring Capital first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
Wealthspring Capital's LAVA Medtech Acquisition Corp. Unit position peaked at $523K in Q4 2021.
6 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q4 2022.

Based on Wealthspring Capital's 13F filing for Q4 2022, filed 8 Feb 2023.